Edda Simoncini

5.1k total citations
99 papers, 2.5k citations indexed

About

Edda Simoncini is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Edda Simoncini has authored 99 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 73 papers in Oncology, 34 papers in Cancer Research and 32 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Edda Simoncini's work include Breast Cancer Treatment Studies (31 papers), Cancer Treatment and Pharmacology (28 papers) and Breast Lesions and Carcinomas (13 papers). Edda Simoncini is often cited by papers focused on Breast Cancer Treatment Studies (31 papers), Cancer Treatment and Pharmacology (28 papers) and Breast Lesions and Carcinomas (13 papers). Edda Simoncini collaborates with scholars based in Italy, Switzerland and United States. Edda Simoncini's co-authors include Aron Goldhirsch, Diana Crivellari, Monica Castiglione‐Gertsch, Alan S. Coates, Richard D. Gelber, Jurij Lindtner, Karen N. Price, Martin F. Fey, Beat Thürlimann and J. Collins and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Journal of Clinical Oncology.

In The Last Decade

Edda Simoncini

96 papers receiving 2.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Edda Simoncini Italy	26	1.7k	1.1k	753	440	360	99	2.5k
Elisabetta Munzone Italy	31	2.4k 1.4×	1.4k 1.3×	765 1.0×	611 1.4×	254 0.7×	129	3.3k
Sami Diab United States	27	1.8k 1.0×	1.0k 1.0×	805 1.1×	812 1.8×	386 1.1×	74	2.8k
Foluso O. Ademuyiwa United States	28	1.3k 0.7×	818 0.8×	490 0.7×	468 1.1×	503 1.4×	91	2.2k
Thomas Bachelot France	28	1.5k 0.9×	858 0.8×	855 1.1×	1.0k 2.4×	243 0.7×	130	3.0k
Carla I. Falkson United States	26	1.8k 1.1×	797 0.8×	528 0.7×	811 1.8×	196 0.5×	95	2.8k
D. Amoroso Italy	23	2.0k 1.2×	925 0.9×	791 1.1×	455 1.0×	668 1.9×	104	2.8k
Per Malmström Sweden	26	1.3k 0.8×	1.1k 1.0×	515 0.7×	1.0k 2.3×	386 1.1×	61	2.6k
G. Peruzzotti Italy	20	1.3k 0.8×	1.2k 1.2×	368 0.5×	460 1.0×	232 0.6×	44	2.1k
Yasuaki Sagara Japan	25	1.8k 1.1×	1.2k 1.1×	656 0.9×	422 1.0×	309 0.9×	109	2.9k
Angela Moliterni Italy	21	2.1k 1.2×	1.7k 1.6×	396 0.5×	321 0.7×	297 0.8×	35	3.0k

Countries citing papers authored by Edda Simoncini

Since Specialization

Citations

This map shows the geographic impact of Edda Simoncini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edda Simoncini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edda Simoncini more than expected).

Fields of papers citing papers by Edda Simoncini

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Edda Simoncini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edda Simoncini. The network helps show where Edda Simoncini may publish in the future.

Co-authorship network of co-authors of Edda Simoncini

This figure shows the co-authorship network connecting the top 25 collaborators of Edda Simoncini. A scholar is included among the top collaborators of Edda Simoncini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Edda Simoncini. Edda Simoncini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Arpino, Grazia, Giampaolo Bianchini, Giuseppe Curigliano, et al.. (2023). Breaking barriers in triple negative breast cancer (TNBC) – Unleashing the power of antibody-drug conjugates (ADCs). Cancer Treatment Reviews. 123. 102672–102672. 32 indexed citations

Licata, Luca, Deborah Cosentini, Rita De Sanctis, et al.. (2023). Multigene signatures for early breast cancer in clinical practice: A report of the Lombardy genomic assays for breast cancer working group. Frontiers in Oncology. 13. 1081885–1081885. 2 indexed citations

Laganà, Marta, Sara Bosio, Bárbara Zanini, et al.. (2023). Is weight gain preventable in women with early breast cancer undergoing chemotherapy? A real-world study on dietary pattern, physical activity, and body weight before and after chemotherapy. Breast Cancer Research and Treatment. 202(3). 461–471. 3 indexed citations

Zamparini, Manuel, Sara Bosio, Vito Amoroso, et al.. (2022). Taste alterations during neo/adjuvant chemotherapy and subsequent follow-up in breast cancer patients: a prospective single-center clinical study. Supportive Care in Cancer. 30(8). 6955–6961. 6 indexed citations

Pedersini, Rebecca, Sara Bosio, Bárbara Zanini, et al.. (2021). Changes in eating habits and food preferences in breast cancer patients undergoing adjuvant chemotherapy. Scientific Reports. 11(1). 12975–12975. 15 indexed citations

Spazzapan, Simon, Pierfranco Conté, Edda Simoncini, et al.. (2017). Updated results from MONALEESA-2, a phase 3 trial of first-line ribociclib + letrozole in hormone receptor-positive (HR+), HER2-negative (HER2–) advanced breast cancer (ABC). Annals of Oncology. 28. vi28–vi28. 1 indexed citations

Pagani, Olivia, Shari Gelber, Marco Colleoni, Karen N. Price, & Edda Simoncini. (2013). Impact of SERM adherence on treatment effect: International Breast Cancer Study Group Trials 13-93 and 14-93. Breast Cancer Research and Treatment. 142(2). 455–459. 16 indexed citations

Buglione, Michela, Salvatore Grisanti, Camillo Almici, et al.. (2012). Circulating Tumour Cells in locally advanced head and neck cancer: Preliminary report about their possible role in predicting response to non-surgical treatment and survival. European Journal of Cancer. 48(16). 3019–3026. 79 indexed citations

Aebi, Stefan, Zijie Sun, Danielle Braun, et al.. (2011). Differential efficacy of three cycles of CMF followed by tamoxifen in patients with ER-positive and ER-negative tumors: Long-term follow up on IBCSG Trial IX. Annals of Oncology. 22(9). 1981–1987. 46 indexed citations

10.

Consoli, Francesca, Giuseppina Arcangeli, Vittorio Ferrari, et al.. (2011). Circulating Tumor Cells and Cardiac Metastasis from Esophageal Cancer: A Case Report. SHILAP Revista de lepidopterología. 4(2). 299–303. 6 indexed citations

11.

Gruber, Guenther, Bernard F. Cole, Monica Castiglione‐Gertsch, et al.. (2008). Extracapsular tumor spread and the risk of local, axillary and supraclavicular recurrence in node-positive, premenopausal patients with breast cancer. Annals of Oncology. 19(8). 1393–1401. 26 indexed citations

12.

Keshaviah, Aparna, Silvia Dellapasqua, Nicole Rotmensz, et al.. (2007). CA15-3 and alkaline phosphatase as predictors for breast cancer recurrence: a combined analysis of seven International Breast Cancer Study Group trials. Annals of Oncology. 18(4). 701–708. 80 indexed citations

13.

Gianni, Lorenzo, Bernard F. Cole, Ilaria Panzini, et al.. (2007). Anemia during adjuvant non-taxane chemotherapy for early breast cancer: Incidence and risk factors from two trials of the International Breast Cancer Study Group. Supportive Care in Cancer. 16(1). 67–74. 12 indexed citations

14.

Colleoni, Marco, Richard D. Gelber, Alan S. Coates, et al.. (2005). Timing of CMF chemotherapy in combination with tamoxifen in postmenopausal women with breast cancer: role of endocrine responsiveness of the tumor. Annals of Oncology. 16(5). 716–725. 16 indexed citations

15.

Vassalli, Lucia, Vittorio Ferrari, Edda Simoncini, et al.. (2001). Solitary breast metastases from a renal cell carcinoma. Breast Cancer Research and Treatment. 68(1). 29–31. 24 indexed citations

16.

Zaniboni, Alberto, et al.. (1993). L-folinic acid and 5-fluorouracil in the treatment of advanced breast cancer: A phase II study. Annals of Oncology. 4. S41–S43. 17 indexed citations

17.

Arcangeli, Giuseppina, Alberto Zaniboni, Salvatore Milano, et al.. (1993). MICE: a new active combination for non-small cell lung cancer. European Journal of Cancer. 29(13). 1848–1850. 6 indexed citations

18.

Zaniboni, Alberto, et al.. (1989). Cyclophosphamide, epirubicin, high-dose folinic acid and 5-fluorouracil (super-FEC) as first-line chemotherapy for advanced breast cancer: Preliminary results. European Journal of Cancer and Clinical Oncology. 25(8). 1151–1155. 11 indexed citations

19.

Marini, Giovanni, et al.. (1987). 5-Fluorouracil and High-Dose Folinic Acid as Salvage Treatment of Advanced Breast Cancer: An Update. Oncology. 44(6). 336–340. 32 indexed citations

20.

Zaniboni, A., Gabriele Di Lorenzo, Edda Simoncini, et al.. (1986). Estrogen and Progesterone Receptor Guideline for Tamoxifen Therapy in Chronic Lymphocytic Leukemia: A Pilot Study. Acta Haematologica. 75(2). 92–95. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact